MarketAnalysisMarketAnalysis
NYSE:PFE

Pfizer Inc. - NYSE:PFE - Comprehensive analysis

Free evaluation through quantitative algorithms Pfizer Inc. - NYSE:PFE

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

6.84

Market

64

Sector

59

Gross Profit Growth Over Prior Year

32.7

Market

96

Sector

84

EBITDA Growth Over Prior Year

86

Market

98

Sector

95

EBITA Growth Over Prior Year

96

Market

98

Sector

94

EBIT Growth Over Prior Year

159

Market

99

Sector

95

Earnings from Cont. Ops. Growth Over Prior Year

271

Market

99

Sector

97

Net Income Growth Over Prior Year

279

Market

98

Sector

96

Normalized Net Income Growth Over Prior Year

111

Market

97

Sector

90

Diluted EPS before Extra Growth Over Prior Year

282

Market

99

Sector

97

A/R Growth Over Prior Year

-0.89

Market

32

Sector

24

Inventory Growth Over Prior Year

6.5

Market

80

Sector

79

PPE Net Growth Over Prior Year

-5.41

Market

14

Sector

46

Total Assets Growth Over Prior Year

-5.79

Market

11

Sector

38

Tangible Book Value Growth Over Prior Year

0

Market

0

Sector

0

Common Equity Growth Over Prior Year

-0.91

Market

31

Sector

54

Cash from Ops. Growth Over Prior Year

46.5

Market

93

Sector

77

CAPEX Growth Over Prior Year

-25.54

Market

11

Sector

35

Dividend per Share Growth Over Prior Year

2.44

Market

43

Sector

95

Levered Free Cash Flow Growth Over Prior Year

659

Market

99

Sector

99

Unlevered Free Cash Flow Growth Over Prior Year

380

Market

98

Sector

97

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

75

Market

89

Sector

76

SG&A Margin %

23.2

Market

71

Sector

36

EBITDA Margin %

36.7

Market

74

Sector

96

EBITA Margin %

34

Market

87

Sector

96

EBIT Margin %

25.7

Market

72

Sector

93

Earnings from Cont. Ops Margin %

12.65

Market

49

Sector

90

Net Income Margin %

12.62

Market

48

Sector

90

Net Income Avail. for Common Margin %

12.6

Market

49

Sector

90

Normalized Net Income Margin %

14.52

Market

72

Sector

93

Levered Free Cash Flow Margin %

20.1

Market

77

Sector

92

Unlevered Free Cash Flow Margin %

23.1

Market

78

Sector

93

Return on Assets %

4.64

Market

45

Sector

83

Return on Capital %

6.37

Market

41

Sector

84

Return on Equity %

9.06

Market

28

Sector

84

Return on Common Equity %

9.05

Market

26

Sector

84

Total Asset Turnover

0.29

Market

27

Sector

47

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 69
Momentum: 22
Growth: 72
Profitability: 58

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

2.62

Market

40

Sector

48

TEV/LTM EBITDA

6.78

Market

13

Sector

54

P/LTM Normalized EPS

14.24

Market

12

Sector

26

P/BV

1.48

Market

16

Sector

45

TEV/LTM Unlevered FCF

11.33

Market

10

Sector

56

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

-14

Market

12

Sector

48

3M Price Performance

-16.1

Market

25

Sector

63

6M Price Performance

-22.17

Market

21

Sector

57

9M Price Performance

-21.04

Market

22

Sector

64

1Y Price Performance

-13.31

Market

32

Sector

71

Start analyzing Pfizer Inc. - NYSE:PFE with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports